New pyrazoline derivatives and their antidepressant activity

European Journal of Medicinal Chemistry

Volumn 45, Issue 9, 2010, Pages 4383-4387

  Kaplanckl, Zafer Asm ^a   Özdemir, Ahmet ^a   Turan Zitouni, Gülhan ^a   Altntop, Mehlika Dilek ^a   Can, Özgür Devrim ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Antidepressant activity; Modified forced swimming test; Pyrazoline; Rota Rod; Tail suspension tests; Triazole

Indexed keywords

1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL 5 YL]THIOACETYL] 3 (2 THIENYL) 5 (3,4 METHYLENEDIOXYPHENYL) 2 PYRAZOLINE; 1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL 5 YL]THIOACETYL] 3 (2 THIENYL) 5 (4 DIMETHYLAMINOPHENYL) 2 PYRAZOLINE; 1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL 5 YL]THIOACETYL] 3 (2 THIENYL) 5 (4 FLOROPHENYL) 2 PYRAZOLINE; 1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL 5 YL]THIOACETYL] 3 (2 THIENYL) 5 (4 METHYLPHENYL) 2 PYRAZOLINE; 1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL 5 YL]THIOACETYL] 3 (2 THIENYL) 5 ARYL 2 PYRAZOLINE; 1 [[4 AMINO 3 [2 (4 HYDROXYPHENYL)ETHYL] 4H 1,2,4 TRIAZOL5 YL]THIOACETYL] 3 (2 THIENYL) 5 (4 CHLOROPHENYL) 2 PYRAZOLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; MALE; MICE; PYRAZOLES; TRIAZOLES;

EID: 77955560793     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.06.011     Document Type: Article

References (32)

1. M.L. Wong, and J. Licinio Nat. Rev. Neurosci. 2 2001 343 351
2. A. Little Am. Fam. Physician 80 2009 167 172
3. C. Richard, and M.D. Shelton J. Clin. Psychiatry 5 2003 27 32
4. A.M. Koenig, and M.E. Thase Pol. Arch. Med. Wewn. 119 2009 478 486
5. O. Berton, and E.J. Nestler Nat. Rev. Neurosci. 7 2006 137 151
6. W. Zhu, S. Ma, R. Qu, and D. Kang Life Sci. 79 2006 749 756
7. J.M. Kane, M.W. Dudley, S.M. Sorensen, and F.P. Miller J. Med. Chem. 31 1988 1253 1258
8. M.C. Sarv, G. Romeo, F. Guerrera, M. Siracusa, L. Salerno, F. Russo, A. Cagnotto, M. Goegan, and T. Mennini Bioorg. Med. Chem. 10 2002 313 323
9. G. Turan-Zitouni, Z.A. Kaplanckl, F.S. Kl, and K. Erol Boll. Chim. Farm. 141 2002 192 196
10. W.E. Heydorn Exp. Opin. Invest. Drugs 4 1995 131 137
11. B. Cusack, A. Nelson, and E. Richelson Psychopharmacology 114 1994 559 565
12. A. O'Brien Receptor Binding in Drug Research 1986 CRC Press FL-USA pp. 151-166
13. E. Przegaliński, and A. Lewandowska J. Neural Transm. 46 1979 303 312
14. W.V. Vieweg Drugs Today (Barc) 34 1998 845 853
15. E. Palaska, M. Aytemir, I.T. Uzbay, and D. Erol Eur. J. Med. Chem. 36 2001 539 543
16. N. Gökhan, A. Yeilada, G. Uar, K. Erol, and A.A. Bilgin Arch. Pharm. 336 2003 362 371
17. F. Chimenti, A. Bolasco, F. Manna, D. Secci, P. Chimenti, A. Granese, O. Befani, P. Turini, R. Cirilli, F. La Torre, S. Alcaro, F. Ortuso, and T. Langer Curr. Med. Chem. 13 2006 1411 1428
18. O.D. Can, U.D. Ozkay, Z.A. Kaplanckl, and Y. Oztürk Arch. Pharm. Res. 32 2009 1293 1299
19. R.A. Kabli, A.A. Khalaf, M.T. Zimaity, A.M. Khalil, A.M. Kaddah, and H.A. Al-Rifaie J. Indian Chem. Soc. 68 1991 47 51
20. A.A. Khalaf, R.A. Kabli, M.T. Zimaity, A.M. Khalil, A.M. Kaddah, and H.A. Al-Rifaie Indian J. Chem. Sect. B 32B 1993 1125 1129
21. G. Turan-Zitouni, A. Özdemir, and K. Güven Arch. Pharm. Chem. Life Sci. 338 2005 96 104
22. V. Vijayabaskar, S. Perumal, S. Selvaraj, A. Lycka, R. Murugan, and M. Balasubramanian Magn. Reson. Chem. 37 1999 133 139
23. I. Ledneczki, P. Forgo, J.T. Kiss, and I. ÁMolnárPá linkó J. Mol. Struct. 834-836 2007 349 354
24. M.J. Detke, and I. Lucki Behav. Brain Res. 73 1996 43 46
25. J.F. Cryan, A. Markou, and I. Lucki Trends Pharmacol. Sci. 23 2002 238 245
26. S. Mora, R. Millán, H. Lungenstrass, G. Díaz-Véliz, J.A. Morán, M. Herrera-Ruiz, and J. Tortoriello J. Ethnopharmacol. 106 2006 76 81
27. L. Steru, R. Chermat, B. Thierry, and P. Simon Psychopharmacology (Berl) 85 1985 367 370
28. D.M. Nielsen, G.J. Carey, and L.H. Gold Eur. J. Pharmacol. 499 2004 135 146
29. Y. Nakatomi, C. Yokoyama, S. Kinoshita, D. Masaki, H. Tsuchida, H. Onoe, K. Yoshimoto, and K. Fukui Neurosci. Lett. 436 2008 167 170
30. M. Tanaka, and G. Telegdy Brain Res. Bull. 77 2008 301 305
31. Z. Tabarelli, M.A. Rubin, D.B. Berlese, P.D. Sauzem, T.P. Missio, M.V. Teixeira, A.P. Sinhorin, M.A.P. Martins, N. Zanatta, H.G. Bonacorso, and C.F. Mello Braz. J. Med. Biol. Res. 37 2004 1531 1540
32. B. Adzu, S. Amos, I. Muazzam, U.S. Inyang, and K.S. Gamaniel J. Ethnopharmacol. 83 2002 139 143